Patents by Inventor Lorenzo Pellegrini

Lorenzo Pellegrini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SCHIZOPHRENIA
    Publication number: 20220274951
    Abstract: Disclosed herein are compositions and methods for treating schizophrenia and symptoms of schizophrenia, including negative symptoms of schizophrenia.
    Type: Application
    Filed: May 16, 2022
    Publication date: September 1, 2022
    Inventors: Remy Henri LUTHRINGER, Lorenzo PELLEGRINI, Argeris N. KARABELAS
  • FORMULATIONS OF LIXIVAPTAN FOR THE TREATMENT OF POLYCYSTIC DISEASE
    Publication number: 20220110944
    Abstract: Formulations of lixivaptan, and methods of using the same, are provided for the treatment of polycystic disease.
    Type: Application
    Filed: December 23, 2021
    Publication date: April 14, 2022
    Applicant: PALLADIO BIOSCIENCES, INC.
    Inventor: Lorenzo PELLEGRINI
  • Formulations of lixivaptan for the treatment of polycystic disease
    Patent number: 11241441
    Abstract: Formulations of lixivaptan, and methods of using the same, are provided for the treatment of polycystic disease.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: February 8, 2022
    Assignee: PALLADIO BIOSCIENCES, INC.
    Inventor: Lorenzo Pellegrini
  • METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SIGMA RECEPTOR MEDIATED DISORDERS
    Publication number: 20210106573
    Abstract: Disclosed herein are compositions and methods for treating a sigma-2 receptor-mediated condition or disorder, including treating one or more symptoms of a sigma-2 receptor-mediated condition or disorder.
    Type: Application
    Filed: June 29, 2020
    Publication date: April 15, 2021
    Inventors: Remy Henri LUTHRINGER, Lorenzo PELLEGRINI, Argeris N. KARABELAS
  • METHODS OF USE OF PHENOXYPROPYLAMINE COMPOUNDS TO TREAT DEPRESSION
    Publication number: 20200223838
    Abstract: Disclosed herein are compositions and methods for treating depression using compositions comprising a compound of formula I. Disclosed herein are compositions and methods for treating depression using compositions comprising phenoxypropylamine compounds and derivatives having selective affinity for and antagonistic activity against the 5-HT1A receptor, as well as 5-HT reuptake inhibitory activity. In addition, compositions and methods for treating depression using compositions comprising a compound of formula II are disclosed. Methods of treating or diminishing at least one symptom of depression in a human subject with a composition comprising a compound of the formula (I) or formula (II), or a pharmaceutically acceptable salt, hydrate, or solvate thereof, are also disclosed.
    Type: Application
    Filed: March 25, 2020
    Publication date: July 16, 2020
    Applicant: Minerva Neurosciences, Inc.
    Inventors: Lorenzo PELLEGRINI, Argeris KARABELAS, Remy LUTHRINGER
  • FORMULATIONS OF LIXIVAPTAN FOR THE TREATMENT OF POLYCYSTIC DISEASE
    Publication number: 20200147102
    Abstract: Formulations of lixivaptan, and methods of using the same, are provided for the treatment of polycystic disease.
    Type: Application
    Filed: June 8, 2018
    Publication date: May 14, 2020
    Applicant: PALLADIO BIOSCIENCES, INC.
    Inventor: Lorenzo PELLEGRINI
  • METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SCHIZOPHRENIA
    Publication number: 20180155318
    Abstract: Disclosed herein are compositions and methods for treating schizophrenia and symptoms of schizophrenia, including negative symptoms of schizophrenia.
    Type: Application
    Filed: July 21, 2017
    Publication date: June 7, 2018
    Inventors: Remy Henri LUTHRINGER, Lorenzo PELLEGRINI, Argeris N. KARABELAS
  • Methods of use of cyclic amide derivatives to treat schizophrenia
    Patent number: 9732059
    Abstract: Disclosed herein are compositions and methods for treating schizophrenia and symptoms of schizophrenia, including negative symptoms of schizophrenia.
    Type: Grant
    Filed: July 20, 2011
    Date of Patent: August 15, 2017
    Assignee: Minerva Neurosciences, Inc.
    Inventors: Remy Henri Luthringer, Lorenzo Pellegrini, Argeris N. Karabelas
  • METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SIGMA RECEPTOR MEDIATED DISORDERS
    Publication number: 20160354357
    Abstract: Disclosed herein are compositions and methods for treating a sigma-2 receptor-mediated condition or disorder, including treating one or more symptoms of a sigma-2 receptor-mediated condition or disorder.
    Type: Application
    Filed: May 24, 2016
    Publication date: December 8, 2016
    Inventors: REMY HENRI LUTHRINGER, LORENZO PELLEGRINI, ARGERIS N. KARABELAS
  • METHODS OF USE OF PHENOXYPROPYLAMINE COMPOUNDS TO TREAT DEPRESSION
    Publication number: 20140206722
    Abstract: Disclosed herein are compositions and methods for treating depression using compositions comprising a compound of formula I. Disclosed herein are compositions and methods for treating depression using compositions comprising phenoxypropylamine compounds and derivatives having selective affinity for and antagonistic activity against the 5-HT1A receptor, as well as 5-HT reuptake inhibitory activity. In addition, compositions and methods for treating depression using compositions comprising a compound of formula II are disclosed. Methods of treating or diminishing at least one symptom of depression in a human subject with a composition comprising a compound of the formula (I) or formula (II), or a pharmaceutically acceptable salt, hydrate, or solvate thereof, are also disclosed.
    Type: Application
    Filed: January 24, 2014
    Publication date: July 24, 2014
    Applicant: MINERVA NEUROSCIENCES, INC.
    Inventors: Lorenzo Pellegrini, Argeris Karabelas, Remy Luthringer
  • METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SCHIZOPHRENIA
    Publication number: 20130274289
    Abstract: Disclosed herein are compositions and methods for treating schizophrenia and symptoms of schizophrenia, including negative symptoms of schizophrenia.
    Type: Application
    Filed: July 20, 2011
    Publication date: October 17, 2013
    Inventors: Remy Henri Luthringer, Lorenzo Pellegrini, Argeris N. Karabelas
  • METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SIGMA RECEPTOR MEDIATED DISORDERS
    Publication number: 20130274290
    Abstract: Disclosed herein are compositions and methods for treating a sigma-2 receptor- mediated condition or disorder, including treating one or more symptoms of a sigma-2 receptor-mediated condition or disorder.
    Type: Application
    Filed: July 20, 2011
    Publication date: October 17, 2013
    Applicant: CYRENAIC PHARMACEUTICALS, INC.
    Inventors: Remy Henri Luthringer, Lorenzo Pellegrini, Argeris N. Karabelas